[ad_1]
NEW YORK (Reuters Health) – A recent medical study has shown that anticancer drugs combine high blood sugar levels and high blood pressure medications. They destroy cancer cells by reducing the amount of energy they need to multiply.
Metformin is one of the most commonly used medications in the treatment and control of type 2 diabetes. It reduces blood sugar by slowing the secretion of glucose in the liver and by absorbing the sugar in the intestines. It also treats insulin resistance by alerting the body's cells to insulin. In addition to treating obesity and helping to lose weight in people without diabetes.
Scientists have highlighted the uses of the drug, described by doctors to help treat polycystic ovarian syndrome, and some researchers have said the drug can improve fertility levels and help regulate menstrual cycles.
Studies have shown that the drug may affect the metabolic processes associated with aging and associated conditions, and clinical trials are underway to evaluate the effects of metformin on age.
Researchers at the Center for Bioinstrom at the University of Basel in Switzerland said that taking this medicine with a medicine to treat high blood pressure could stop the growth of cancerous tumors.
In the new research, scientists have shown how this association works by showing that the combination of metformin and ribosingubine, which reduces arterial hypertension, reduces the energy supply of cancerous tumors, resulting in the death of malignant cells.
The researchers explain how this happens when cancer cells need a lot of energy to grow and spread quickly, but there is a barrier to cancer metabolism: NAD +, this molecule turns nutrients into energy. In order to maintain the operation of energy-generating machines, NAD + must be generated continuously, but these drugs prevent the production of this molecule.
Source: New
[ad_2]
Source link
